Listen to the latest Hemonc news
from international experts
Bladder cancer: advances in the spotlight and what these mean for therapy
Over the past few years, the field of bladder cancer has seen an array of exciting clinical advancements, ranging from novel therapies, to prognostic biomarkers and disease biology. Exploring these developments and their implications, this podcast features Thomas Powles of Barts Cancer Institute, Andrea Apolo of the National Cancer Institute, Rob Jones of the University of Glasgow & Beatson West of Scotland Cancer Centre, and Arlene Siefker-Radtke of the MD Anderson Cancer Center.
Footage of the speakers was recorded at the 2018 Genitourinary (GU) Cancers Symposium and the American Society of Oncology (ASCO) 2018 Annual Meeting.
Date: 16th August 2018